EP 1620121 A2 20060201 - THE USE OF A POLYPEPTIDE DOMAIN OF SLPI TO MODULATE THE TUMORIGENIC AND METASTATIC POTENTIAL OF CANCER CELLS
Title (en)
THE USE OF A POLYPEPTIDE DOMAIN OF SLPI TO MODULATE THE TUMORIGENIC AND METASTATIC POTENTIAL OF CANCER CELLS
Title (de)
VERWENDUNG EINES POLYPEPTIDTEIL VON SLPI ZUR MODULIERUNG DES TUMOR- UND METASTASE POTENTIEL DER KREBSZELLEN
Title (fr)
UTILISATION D'UN DOMAINE POLYPEPTIDIQUE POUR MODULER LE POTENTIEL TUMORIGENE ET METASTATIQUE DE CELLULES CANCEREUSES
Publication
Application
Priority
- EP 2004050627 W 20040428
- EP 03101265 A 20030507
- EP 04729903 A 20040428
Abstract (en)
[origin: WO2004098626A2] The present invention relates to the use of a polypeptide domain to modulate the tumorigenic and metastatic potential of cancer cells. More specifically, the present invention relates to a domain of a Secretory Leukocyte Protease Inhibitor (SLPI) to modulate tumor invasiveness and/or metastasis. It further relates to compounds, such as antibodies, that interact with said domain and repress the tumor invasiveness and/or the metastasis.
IPC 1-7
IPC 8 full level
A61K 38/57 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 38/57 (2013.01 - EP US); A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 2004098626A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004098626 A2 20041118; WO 2004098626 A3 20041209; WO 2004098626 A8 20050317; CA 2524626 A1 20041118; EP 1620121 A2 20060201; US 2006111294 A1 20060525; US 2008199472 A1 20080821
DOCDB simple family (application)
EP 2004050627 W 20040428; CA 2524626 A 20040428; EP 04729903 A 20040428; US 26907005 A 20051107; US 7023908 A 20080214